Literature DB >> 21542104

Noncalcified plaque: relationship between results of multislice computed tomography, risk factors, and late clinical outcome.

Niti R Aggarwal1, Thomas Knickelbine, Aaron Tande, Luke Stoltzfus, John R Lesser, Robert S Schwartz.   

Abstract

BACKGROUND: Contrast-enhanced multislice computed tomographic angiography (MSCTA) detects noncalcified plaque (NCP) in coronary arteries and associated coronary stenoses. However, the clinical relevance of NCP is poorly defined.
OBJECTIVES: Our goal was to examine the relationship NCP, risk factors (RFs), and clinical follow-up in unselected outpatients undergoing MSCTA.
METHODS: Five hundred six patients undergoing contrast MSCTA were evaluated for NCP (intraluminal density 25 < Hounsfield units < 130). One hundred twenty-four patients (24.5%) had calcium scores (CAC) of zero. Of these, 111 patients were examined for RFs and followed clinically for a mean of 34 months.
RESULTS: Of 124 patients with zero CAC, 111 (89.5%) included 52 (46.8%) with no NCP, 40 (36.0%) with NCP, and mild luminal stenosis, 14 (12.6%) and 5 (4.5%) with NCP causing significant and severe stenosis, respectively. Patients in each group were similar in age but differed significantly in number of RFs. Current or former smokers, hypertensive, and obese patients had more NCP and associated stenosis. At a mean of 34 months, there were no events in the no NCP group, 2/54 (3.7%) events in the NCP without severe stenosis group (one sudden cardiac death and one ventricular tachycardia), and 2/5 (40.0%) patients had revascularization in the NCP with severe stenosis group.
CONCLUSIONS: (1) In patients with zero CAC, presence of NCP on MSCTA was associated with more RFs, especially smoking, obesity, and hypertension. (2) NCP can result in severe coronary stenosis. (3) NCP detected by MSCTA in patients with zero CAC may identify patients with late cardiac events.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21542104     DOI: 10.1002/ccd.23138

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Interobserver agreement for the detection of atherosclerotic plaque in coronary CT angiography: comparison of two low-dose image acquisition protocols with standard retrospectively ECG-gated reconstruction.

Authors:  Annika Schuhbäck; Mohamed Marwan; Sören Gauss; Gerd Muschiol; Dieter Ropers; Christian Schneider; Michael Lell; Johannes Rixe; Christian Hamm; Werner G Daniel; Stephan Achenbach
Journal:  Eur Radiol       Date:  2012-03-27       Impact factor: 5.315

2.  Semiquantified noncalcified coronary plaque in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Jens Vogel-Claussen; Armin Arbab-Zadeh; Laurence S Magder; Joao Lima; Michelle Petri
Journal:  J Rheumatol       Date:  2012-10-01       Impact factor: 4.666

3.  Beyond Coronary Stenosis: Coronary Computed Tomographic Angiography for the Assessment of Atherosclerotic Plaque Burden.

Authors:  Alan C Kwan; George Cater; Jose Vargas; David A Bluemke
Journal:  Curr Cardiovasc Imaging Rep       Date:  2013-01-22

4.  Coronary CT angiography findings based on smoking status: Do ex-smokers and never-smokers share a low probability of developing coronary atherosclerosis?

Authors:  Minkyung Yi; Eun Ju Chun; Min Su Lee; Jaebong Lee; Sang Il Choi
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-11       Impact factor: 2.357

5.  Usefulness of coronary computed tomography angiography evaluating the clinical importance of coronary artery calcium and noncalcified plaque in asymptomatic patients.

Authors:  Young Joon Hong
Journal:  Korean Circ J       Date:  2013-03       Impact factor: 3.243

6.  Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Cecilia P Chung; Jon T Giles; Richard A Kronmal; Wendy S Post; Allan C Gelber; Michelle Petri; Moyses Szklo; Robert Detrano; Matthew J Budoff; Roger S Blumenthal; Pamela Ouyang; David Bush; Joan M Bathon
Journal:  Arthritis Res Ther       Date:  2013-09-25       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.